HALO logo
halo search icon
Spyre Therapeutics, Inc

US$71.92

Price Change Indicator
5.30 (7.96%)
Spyre Therapeutics, Inc
SYRE · NAS

Spyre Therapeutics, Inc

Start Trading SYRE for Free

US$71.92

Price Arrow5.30 (7.96%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Price MomentumHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Spyre Therapeutics, Inc Overview

SYRE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About SYRE

icon
icon

Telephone

1.617.651.5940

icon

Address

Suite 105, 221 Crescent Street, Building 23, Waltham, MA 02453

Description

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

SYRE Price Chart

Key Stats

Market Cap

US$5.79B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 13.93 - 78.8

Trade Value (12mth)

US$7,207,019.00

1 week

-11.08%

1 month

-6.52%

YTD

117.85%

1 year

350.74%

All time high

318.75

Key Fundamentals

EPS 3 yr Growth

-92.10%

EBITDA Margin

0.00%

Operating Cashflow

-$169m

Free Cash Flow Return

-27.50%

ROIC

-20.50%

Interest Coverage

0.00

Quick Ratio

13.30

Other Data

Shares Outstanding (Fully Diluted)

79m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SYRE Announcements

Latest Announcements

DateAnnouncements
05 May 26
05 May 26
05 May 26
02 May 26
02 May 26

SYRE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-13.76-3.18-1.98locklocklock
EPS (Fully Diluted)
 $locklocklocklock-13.76-3.18-1.98locklocklock
Growth
 %locklocklocklock44.776.937.9locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Spyre Therapeutics, Inc (SYRE:NAS)?
Halo FAQ
The current share price of Spyre Therapeutics, Inc (SYRE:NAS) is USD$71.92.
What is the 52-week high share price for Spyre Therapeutics, Inc (SYRE:NAS)?
Halo FAQ
The 52-week high share price for Spyre Therapeutics, Inc (SYRE:NAS) is USD$78.80.
What is the 52-week low share price for Spyre Therapeutics, Inc (SYRE:NAS)?
Halo FAQ
The 52-week low share price for Spyre Therapeutics, Inc (SYRE:NAS) is USD$13.93.
What is the dividend yield for Spyre Therapeutics, Inc (SYRE:NAS)?
Halo FAQ
Spyre Therapeutics, Inc (SYRE:NAS) does not pay a dividend.
What was Spyre Therapeutics, Inc (SYRE:NAS) last dividend payment?
Halo FAQ
Spyre Therapeutics, Inc (SYRE:NAS) does not pay a dividend.
What is the franking level for Spyre Therapeutics, Inc (SYRE:NAS)?
Halo FAQ
Spyre Therapeutics, Inc (SYRE:NAS) has a franking level of 0.00%.
In which sector is Spyre Therapeutics, Inc (SYRE:NAS) classified?
Halo FAQ
Spyre Therapeutics, Inc (SYRE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial